392 related articles for article (PubMed ID: 11176912)
1. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.
Welliver R; Monto AS; Carewicz O; Schatteman E; Hassman M; Hedrick J; Jackson HC; Huson L; Ward P; Oxford JS;
JAMA; 2001 Feb; 285(6):748-54. PubMed ID: 11176912
[TBL] [Abstract][Full Text] [Related]
2. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.
Hayden FG; Treanor JJ; Fritz RS; Lobo M; Betts RF; Miller M; Kinnersley N; Mills RG; Ward P; Straus SE
JAMA; 1999 Oct; 282(13):1240-6. PubMed ID: 10517426
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
Treanor JJ; Hayden FG; Vrooman PS; Barbarash R; Bettis R; Riff D; Singh S; Kinnersley N; Ward P; Mills RG
JAMA; 2000 Feb; 283(8):1016-24. PubMed ID: 10697061
[TBL] [Abstract][Full Text] [Related]
4. Oseltamivir: a review of its use in influenza.
McClellan K; Perry CM
Drugs; 2001; 61(2):263-83. PubMed ID: 11270942
[TBL] [Abstract][Full Text] [Related]
5. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus.
Ng S; Cowling BJ; Fang VJ; Chan KH; Ip DK; Cheng CK; Uyeki TM; Houck PM; Malik Peiris JS; Leung GM
Clin Infect Dis; 2010 Mar; 50(5):707-14. PubMed ID: 20121573
[TBL] [Abstract][Full Text] [Related]
6. Neuraminidase inhibitors for preventing and treating influenza in children.
Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
[TBL] [Abstract][Full Text] [Related]
7. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.
Hayden FG; Belshe R; Villanueva C; Lanno R; Hughes C; Small I; Dutkowski R; Ward P; Carr J
J Infect Dis; 2004 Feb; 189(3):440-9. PubMed ID: 14745701
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China.
Li L; Cai B; Wang M; Zhu Y
Chin Med J (Engl); 2003 Jan; 116(1):44-8. PubMed ID: 12667386
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase inhibitors: zanamivir and oseltamivir.
McNicholl IR; McNicholl JJ
Ann Pharmacother; 2001 Jan; 35(1):57-70. PubMed ID: 11197587
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population.
Peters PH; Gravenstein S; Norwood P; De Bock V; Van Couter A; Gibbens M; von Planta TA; Ward P
J Am Geriatr Soc; 2001 Aug; 49(8):1025-31. PubMed ID: 11555062
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial].
Kashiwagi S; Kudoh S; Watanabe A; Yoshimura I
Kansenshogaku Zasshi; 2000 Dec; 74(12):1062-76. PubMed ID: 11193558
[TBL] [Abstract][Full Text] [Related]
13. Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
Jefferson TO; Demicheli V; Di Pietrantonj C; Jones M; Rivetti D
Cochrane Database Syst Rev; 2006 Jul; (3):CD001265. PubMed ID: 16855962
[TBL] [Abstract][Full Text] [Related]
14. Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Trujillo A; Barnes J; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2015 Jun; 15(6):654-62. PubMed ID: 25788164
[TBL] [Abstract][Full Text] [Related]
15. [A multicenter study of efficacy and safety of oseltamivir in treatment of naturally acquired influenza].
Li L; Cai B; Wang M; Zhu Y
Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):838-42. PubMed ID: 16206676
[TBL] [Abstract][Full Text] [Related]
16. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
Hayden FG; Atmar RL; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills RG
N Engl J Med; 1999 Oct; 341(18):1336-43. PubMed ID: 10536125
[TBL] [Abstract][Full Text] [Related]
17. Neuraminidase inhibitors for preventing and treating influenza in children.
Matheson NJ; Harnden AR; Perera R; Sheikh A; Symmonds-Abrahams M
Cochrane Database Syst Rev; 2007 Jan; (1):CD002744. PubMed ID: 17253479
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.
Nicholson KG; Aoki FY; Osterhaus AD; Trottier S; Carewicz O; Mercier CH; Rode A; Kinnersley N; Ward P
Lancet; 2000 May; 355(9218):1845-50. PubMed ID: 10866439
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase inhibitors for preventing and treating influenza in children.
Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
[TBL] [Abstract][Full Text] [Related]
20. Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
Carrat F; Duval X; Tubach F; Mosnier A; Van der Werf S; Tibi A; Blanchon T; Leport C; Flahault A; Mentré F;
Antivir Ther; 2012; 17(6):1085-90. PubMed ID: 22910171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
